2024-06-04
Jan 2018
Invested in self-developedprojectBMR01DL, in cooperation with China Pharmaceutical University
More +2024-06-04
Invested in self-developedprojectBMR01DL, in cooperation with China Pharmaceutical University
More +2024-06-04
Sales exceeded 100 million RMB. Determined the dual-drive strategy of R&D& in-licensing
2024-06-04
Sales exceeded 100 million RMB. Determined the dual-drive strategy of R&D& in-licensing
2024-06-04
Wholly acquired Shenzhen Xieran Pharmaceutical Co., Ltd., and renamed to Shenzhen Beimei Pharmaceutical Co., Ltd.，and established the strategic direction of focusing on "pediatric prescription medicines"
2024-06-04
Wholly acquired Shenzhen Xieran Pharmaceutical Co., Ltd., and renamed to Shenzhen Beimei Pharmaceutical Co., Ltd.，and established the strategic direction of focusing on "pediatric prescription medicines"
2024-06-04
Acquired 9 medicine approvals of Haibin Pharma, and completed technology transfer,GMP certification of new plants, and marketing promotion
2024-06-04
Acquired 9 medicine approvals of Haibin Pharma, and completed technology transfer,GMP certification of new plants, and marketing promotion